Lars Lannfelt
Professor emeritus at Department of Public Health and Caring Sciences; Molecular Geriatrics / Rudbeck laboratory
- E-mail:
- lars.lannfelt@uu.se
- Visiting address:
- Dag Hammarskjölds väg 20
- Postal address:
- Rudbecklaboratoriet
751 85 Uppsala
Publications
Recent publications
-
The Uppsala APP mutation promotes wildtype Aβ aggregation and deposition in vivo
Part of Advanced Science, 2026
- DOI for The Uppsala APP mutation promotes wildtype Aβ aggregation and deposition in vivo
- Download full text (pdf) of The Uppsala APP mutation promotes wildtype Aβ aggregation and deposition in vivo
-
Part of Neuroscience Letters, 2026
- DOI for Lecanemab promotes Fc receptor-dependent cell-mediated internalization and degradation of aggregated amyloid-beta in vitro and ex vivo
- Download full text (pdf) of Lecanemab promotes Fc receptor-dependent cell-mediated internalization and degradation of aggregated amyloid-beta in vitro and ex vivo
-
Part of Nature Aging, p. 366-375, 2025
- DOI for Soluble cerebral Aβ protofibrils link Aβ plaque pathology to changes in CSF Aβ42/Aβ40 ratios, neurofilament light and tau in Alzheimer’s disease model micece
- Download full text (pdf) of Soluble cerebral Aβ protofibrils link Aβ plaque pathology to changes in CSF Aβ42/Aβ40 ratios, neurofilament light and tau in Alzheimer’s disease model micece
-
Part of Molecular and Cellular Neuroscience, 2024
- DOI for Lecanemab demonstrates highly selective binding to Aβ protofibrils isolated from Alzheimer's disease brains
- Download full text (pdf) of Lecanemab demonstrates highly selective binding to Aβ protofibrils isolated from Alzheimer's disease brains
-
Part of Molecular and Cellular Neuroscience, 2024
- DOI for Disease modifying effects of the amyloid-beta protofibril-selective antibody mAb158 in aged Tg2576 transgenic mice
- Download full text (pdf) of Disease modifying effects of the amyloid-beta protofibril-selective antibody mAb158 in aged Tg2576 transgenic mice
All publications
Articles in journal
-
The Uppsala APP mutation promotes wildtype Aβ aggregation and deposition in vivo
Part of Advanced Science, 2026
- DOI for The Uppsala APP mutation promotes wildtype Aβ aggregation and deposition in vivo
- Download full text (pdf) of The Uppsala APP mutation promotes wildtype Aβ aggregation and deposition in vivo
-
Part of Neuroscience Letters, 2026
- DOI for Lecanemab promotes Fc receptor-dependent cell-mediated internalization and degradation of aggregated amyloid-beta in vitro and ex vivo
- Download full text (pdf) of Lecanemab promotes Fc receptor-dependent cell-mediated internalization and degradation of aggregated amyloid-beta in vitro and ex vivo
-
Part of Nature Aging, p. 366-375, 2025
- DOI for Soluble cerebral Aβ protofibrils link Aβ plaque pathology to changes in CSF Aβ42/Aβ40 ratios, neurofilament light and tau in Alzheimer’s disease model micece
- Download full text (pdf) of Soluble cerebral Aβ protofibrils link Aβ plaque pathology to changes in CSF Aβ42/Aβ40 ratios, neurofilament light and tau in Alzheimer’s disease model micece
-
Part of Molecular and Cellular Neuroscience, 2024
- DOI for Lecanemab demonstrates highly selective binding to Aβ protofibrils isolated from Alzheimer's disease brains
- Download full text (pdf) of Lecanemab demonstrates highly selective binding to Aβ protofibrils isolated from Alzheimer's disease brains
-
Part of Molecular and Cellular Neuroscience, 2024
- DOI for Disease modifying effects of the amyloid-beta protofibril-selective antibody mAb158 in aged Tg2576 transgenic mice
- Download full text (pdf) of Disease modifying effects of the amyloid-beta protofibril-selective antibody mAb158 in aged Tg2576 transgenic mice
-
Part of Scientific Reports, 2024
- DOI for Amyloid-beta antibody binding to cerebral amyloid angiopathy fibrils and risk for amyloid-related imaging abnormalities
- Download full text (pdf) of Amyloid-beta antibody binding to cerebral amyloid angiopathy fibrils and risk for amyloid-related imaging abnormalities
-
Part of Acta neuropathologica communications, 2024
- DOI for Altered amyloid-β structure markedly reduces gliosis in the brain of mice harboring the Uppsala APP deletion
- Download full text (pdf) of Altered amyloid-β structure markedly reduces gliosis in the brain of mice harboring the Uppsala APP deletion
-
Part of Neurotherapeutics, p. 195-206, 2023
- DOI for Lecanemab, Aducanumab, and Gantenerumab - Binding Profiles to Different Forms of Amyloid-Beta Might Explain Efficacy and Side Effects in Clinical Trials for Alzheimer's Disease
- Download full text (pdf) of Lecanemab, Aducanumab, and Gantenerumab - Binding Profiles to Different Forms of Amyloid-Beta Might Explain Efficacy and Side Effects in Clinical Trials for Alzheimer's Disease
-
Part of AGING BRAIN, 2023
- DOI for Reduction of brain stem pathology and transient amelioration of early cognitive symptoms in transgenic mice treated with a monoclonal antibody against α-synuclein oligomers/protofibrils
- Download full text (pdf) of Reduction of brain stem pathology and transient amelioration of early cognitive symptoms in transgenic mice treated with a monoclonal antibody against α-synuclein oligomers/protofibrils
-
The amyloid-beta pathway in Alzheimer's disease: a plain language summary
Part of Neurodegenerative Disease Management, p. 141-149, 2023
- DOI for The amyloid-beta pathway in Alzheimer's disease: a plain language summary
- Download full text (pdf) of The amyloid-beta pathway in Alzheimer's disease: a plain language summary
-
Part of BMC Genomics, 2022
- DOI for Mutation analysis of disease causing genes in patients with early onset or familial forms of Alzheimer’s disease and frontotemporal dementia
- Download full text (pdf) of Mutation analysis of disease causing genes in patients with early onset or familial forms of Alzheimer’s disease and frontotemporal dementia
-
A beta and tau prions feature in the neuropathogenesis of Down syndrome
Part of Proceedings of the National Academy of Sciences of the United States of America, 2022
-
Part of Science Translational Medicine, 2021
-
Part of Translational Neurodegeneration, 2021
- DOI for Novel multivalent design of a monoclonal antibody improves binding strength to soluble aggregates of amyloid beta
- Download full text (pdf) of Novel multivalent design of a monoclonal antibody improves binding strength to soluble aggregates of amyloid beta
-
Part of Neurobiology of Disease, 2021
- DOI for ABBV-0805, a novel antibody selective for soluble aggregated alpha-synuclein, prolongs lifespan and prevents buildup of alpha-synuclein pathology in mouse models of Parkinson's disease
- Download full text (pdf) of ABBV-0805, a novel antibody selective for soluble aggregated alpha-synuclein, prolongs lifespan and prevents buildup of alpha-synuclein pathology in mouse models of Parkinson's disease
-
Part of Neuroscience Letters, 2021
- DOI for Characterization of monomeric and soluble aggregated A beta in Down's syndrome and Alzheimer's disease brains
- Download full text (pdf) of Characterization of monomeric and soluble aggregated A beta in Down's syndrome and Alzheimer's disease brains
-
Elevated soluble amyloid beta protofibrils in Down syndrome and Alzheimer's disease
Part of Molecular and Cellular Neuroscience, 2021
-
Part of Acta neuropathologica communications, 2021
- DOI for Heparanase overexpression impedes perivascular clearance of amyloid-beta from murine brain: relevance to Alzheimer's disease
- Download full text (pdf) of Heparanase overexpression impedes perivascular clearance of amyloid-beta from murine brain: relevance to Alzheimer's disease
-
Part of Alzheimer's Research & Therapy, 2021
- DOI for A randomized, double-blind, phase 2b proof-of-concept clinical trial in early Alzheimer's disease with lecanemab, an anti-A beta protofibril antibody
- Download full text (pdf) of A randomized, double-blind, phase 2b proof-of-concept clinical trial in early Alzheimer's disease with lecanemab, an anti-A beta protofibril antibody
-
Alzheimers sjukdom – diagnostik och behandling i dag och i framtiden
Part of Läkartidningen, 2020
-
Part of Nature Genetics, p. 1314-1332, 2020
-
Part of European Journal of Human Genetics, p. 349-357, 2020
- DOI for Longitudinal changes in the frequency of mosaic chromosome Y loss in peripheral blood cells of aging men varies profoundly between individuals
- Download full text (pdf) of Longitudinal changes in the frequency of mosaic chromosome Y loss in peripheral blood cells of aging men varies profoundly between individuals
-
Fluorine-18-Labeled Antibody Ligands for PET Imaging of Amyloid-β in Brain
Part of ACS Chemical Neuroscience, p. 4460-4468, 2020
- DOI for Fluorine-18-Labeled Antibody Ligands for PET Imaging of Amyloid-β in Brain
- Download full text (pdf) of Fluorine-18-Labeled Antibody Ligands for PET Imaging of Amyloid-β in Brain
-
Development of Risk Prediction Equations for Incident Chronic Kidney Disease
Part of Journal of the American Medical Association (JAMA), p. 2104-2114, 2019
-
Part of Nature Genetics, p. 414-430, 2019
-
Mosaic loss of chromosome Y in leukocytes matters
Part of Nature Genetics, p. 4-7, 2019
-
Part of Neurobiology of Aging, p. 40-47, 2019
-
A beta and tau prion-like activities decline with longevity in the Alzheimer's disease human brain
Part of Science Translational Medicine, 2019
-
Part of Journal of Alzheimer's Disease, p. 639-651, 2019
- DOI for Improved Differential Diagnosis of Alzheimer's Disease by Integrating ELISA and Mass Spectrometry-Based Cerebrospinal Fluid Biomarkers
- Download full text (pdf) of Improved Differential Diagnosis of Alzheimer's Disease by Integrating ELISA and Mass Spectrometry-Based Cerebrospinal Fluid Biomarkers
-
Atrial fibrillation genetic risk differentiates cardioembolic stroke from other stroke subtypes
Part of Neurology Genetics, 2018
- DOI for Atrial fibrillation genetic risk differentiates cardioembolic stroke from other stroke subtypes
- Download full text (pdf) of Atrial fibrillation genetic risk differentiates cardioembolic stroke from other stroke subtypes
-
Part of Molecular Therapy Nucleic Acids, p. 429-440, 2018
- DOI for CRISPR/Cas9 Mediated Disruption of the Swedish APP Allele as a Therapeutic Approach for Early-Onset Alzheimer's Disease
- Download full text (pdf) of CRISPR/Cas9 Mediated Disruption of the Swedish APP Allele as a Therapeutic Approach for Early-Onset Alzheimer's Disease
-
Part of Journal of Neuroinflammation, 2018
- DOI for The A beta protofibril selective antibody mAb158 prevents accumulation of A beta in astrocytes and rescues neurons from A beta-induced cell death
- Download full text (pdf) of The A beta protofibril selective antibody mAb158 prevents accumulation of A beta in astrocytes and rescues neurons from A beta-induced cell death
-
Part of The Journal of Prevention of Alzheimer's Disease, p. 207-212, 2018
-
Part of Journal of Nuclear Medicine, p. 1885-1891, 2018
- DOI for Antibody-Based In Vivo PET Imaging Detects Amyloid-beta Reduction in Alzheimer Transgenic Mice After BACE-1 Inhibition
- Download full text (pdf) of Antibody-Based In Vivo PET Imaging Detects Amyloid-beta Reduction in Alzheimer Transgenic Mice After BACE-1 Inhibition
-
Rapid amyloid-β oligomer and protofibril accumulation in traumatic brain injury
Part of Brain Pathology, p. 451-462, 2018
-
Part of Alzheimer's Research & Therapy, 2018
- DOI for Efficient clearence of A beta protofibrils in A beta PP-transgenic mice treated with a brain-penetrating bifunctional antibody
- Download full text (pdf) of Efficient clearence of A beta protofibrils in A beta PP-transgenic mice treated with a brain-penetrating bifunctional antibody
-
[F-18]Tetrazine-trans-cyclooctene mediated labelling of antibodies for PET imaging of amyloid-beta
Part of European Journal of Nuclear Medicine and Molecular Imaging, 2018
-
Alzheimer's disease pathology propagation by exosomes containing toxic amyloid-beta oligomers
Part of Acta Neuropathologica, p. 41-56, 2018
- DOI for Alzheimer's disease pathology propagation by exosomes containing toxic amyloid-beta oligomers
- Download full text (pdf) of Alzheimer's disease pathology propagation by exosomes containing toxic amyloid-beta oligomers
-
Part of Proceedings of the National Academy of Sciences of the United States of America, 2018
- DOI for Structural heterogeneity and intersubject variability of A beta in familial and sporadic Alzheimer's disease
- Download full text (pdf) of Structural heterogeneity and intersubject variability of A beta in familial and sporadic Alzheimer's disease
-
Part of Biological Procedures Online, 2017
- DOI for Efficient and inexpensive transient expression of multispecific multivalent antibodies in Expi293 cells
- Download full text (pdf) of Efficient and inexpensive transient expression of multispecific multivalent antibodies in Expi293 cells
-
Part of The Lancet Diabetes and Endocrinology, p. 718-728, 2017
-
Part of Journal of Cerebral Blood Flow and Metabolism, p. 415-416, 2017
-
Part of Atherosclerosis, p. 196-204, 2017
- DOI for Identification of a novel proinsulin-associated SNP and demonstration that proinsulin is unlikely to be a causal factor in subclinical vascular remodelling using Mendelian randomisation
- Download full text (pdf) of Identification of a novel proinsulin-associated SNP and demonstration that proinsulin is unlikely to be a causal factor in subclinical vascular remodelling using Mendelian randomisation
-
Part of Scientific Data, 2017
- DOI for Data Descriptor: Sequence data and association statistics from 12,940 type 2 diabetes cases and controls
- Download full text (pdf) of Data Descriptor: Sequence data and association statistics from 12,940 type 2 diabetes cases and controls
-
Part of Nature Genetics, p. 946-+, 2017
-
Part of Nature Genetics, p. 1373-+, 2017
-
Part of Journal of Neuroinflammation, 2017
- DOI for Alpha-synuclein oligomer-selective antibodies reduce intracellular accumulation and mitochondrial impairment in alpha-synuclein exposed astrocytes
- Download full text (pdf) of Alpha-synuclein oligomer-selective antibodies reduce intracellular accumulation and mitochondrial impairment in alpha-synuclein exposed astrocytes
-
Cognitive function in very old men does not correlate to biomarkers of Alzheimer's disease
Part of BMC Geriatrics, 2017
- DOI for Cognitive function in very old men does not correlate to biomarkers of Alzheimer's disease
- Download full text (pdf) of Cognitive function in very old men does not correlate to biomarkers of Alzheimer's disease
-
Bivalent Brain Shuttle Increases Antibody Uptake by Monovalent Binding to the Transferrin Receptor
Part of Theranostics, p. 308-318, 2017
- DOI for Bivalent Brain Shuttle Increases Antibody Uptake by Monovalent Binding to the Transferrin Receptor
- Download full text (pdf) of Bivalent Brain Shuttle Increases Antibody Uptake by Monovalent Binding to the Transferrin Receptor
-
Decreased HHV-6 IgG in Alzheimer's Disease
Part of Frontiers in Neurology, 2017
-
An Expanded Genome-Wide Association Study of Type 2 Diabetes in Europeans
Part of Diabetes, p. 2888-2902, 2017
-
Mapping of Surface-Exposed Epitopes of In Vitro and In Vivo Aggregated Species of Alpha-Synuclein
Part of Cellular and molecular neurobiology, p. 1217-1226, 2017
- DOI for Mapping of Surface-Exposed Epitopes of In Vitro and In Vivo Aggregated Species of Alpha-Synuclein
- Download full text (pdf) of Mapping of Surface-Exposed Epitopes of In Vitro and In Vivo Aggregated Species of Alpha-Synuclein
-
Part of Neuropharmacology, p. 293-300, 2017
-
Part of Cellular and molecular neurobiology, p. 121-131, 2017
-
Part of Glia, 2017
-
Antibody-based PET radioligands for imaging of amyloid-beta protofibrils
Part of Journal of Cerebral Blood Flow and Metabolism, p. 84-84, 2017
-
Part of Diabetes, p. 2019-2032, 2017
-
Part of Journal of the International Neuropsychological Society, p. 195-203, 2017
-
Part of NeuroImage, p. 55-63, 2017
- DOI for A bispecific Tribody PET radioligand for visualization of amyloid-beta protofibrils - a new concept for neuroimaging
- Download full text (pdf) of A bispecific Tribody PET radioligand for visualization of amyloid-beta protofibrils - a new concept for neuroimaging
-
Part of Gene, p. 139-145, 2016
-
Mosaic Loss of Chromosome Y in Blood Is Associated with Alzheimer Disease
Part of American Journal of Human Genetics, p. 1208-1219, 2016
- DOI for Mosaic Loss of Chromosome Y in Blood Is Associated with Alzheimer Disease
- Download full text (pdf) of Mosaic Loss of Chromosome Y in Blood Is Associated with Alzheimer Disease
-
Part of Nature Genetics, p. 1151-1161, 2016
-
Antibody-based PET imaging of amyloid beta in mouse models of Alzheimer's disease
Part of Nature Communications, 2016
- DOI for Antibody-based PET imaging of amyloid beta in mouse models of Alzheimer's disease
- Download full text (pdf) of Antibody-based PET imaging of amyloid beta in mouse models of Alzheimer's disease
-
Part of Molecular Neurodegeneration, 2016
- DOI for Accumulation of amyloid-beta by astrocytes result in enlarged endosomes and microvesicle-induced apoptosis of neurons
- Download full text (pdf) of Accumulation of amyloid-beta by astrocytes result in enlarged endosomes and microvesicle-induced apoptosis of neurons
-
Part of Molecular Neurodegeneration, 2016
-
The genetic architecture of type 2 diabetes
Part of Nature, p. 41-47, 2016
-
Analysis of the Cerebrospinal Fluid Proteome in Alzheimer's Disease
Part of PLOS ONE, 2016
- DOI for Analysis of the Cerebrospinal Fluid Proteome in Alzheimer's Disease
- Download full text (pdf) of Analysis of the Cerebrospinal Fluid Proteome in Alzheimer's Disease
-
Part of Alzheimer's Research & Therapy, 2016
- DOI for High tau levels in cerebrospinal fluid predict nursing home placement and rapid progression in Alzheimer's disease
- Download full text (pdf) of High tau levels in cerebrospinal fluid predict nursing home placement and rapid progression in Alzheimer's disease
-
Part of Alzheimer's Research & Therapy, 2016
- DOI for Safety and tolerability of BAN2401 - a clinical study in Alzheimer's disease with a protofibril selective A beta antibody
- Download full text (pdf) of Safety and tolerability of BAN2401 - a clinical study in Alzheimer's disease with a protofibril selective A beta antibody
-
Part of Journal of Alzheimer's Disease, p. 1671-1686, 2016
-
Part of PROTEOMICS - Clinical Applications, p. 1242-1253, 2016
- DOI for CSF profiling of the human brain enriched proteome reveals associations of neuromodulin and neurogranin to Alzheimer's disease
- Download full text (pdf) of CSF profiling of the human brain enriched proteome reveals associations of neuromodulin and neurogranin to Alzheimer's disease
-
Part of Acta neuropathologica communications, 2016
- DOI for Deposition of C-terminally truncated A beta species A beta 37 and A beta 39 in Alzheimer's disease and transgenic mouse models
- Download full text (pdf) of Deposition of C-terminally truncated A beta species A beta 37 and A beta 39 in Alzheimer's disease and transgenic mouse models
-
Quantitative Interaction Proteomics of Neurodegenerative Disease Proteins
Part of Cell Reports, p. 1134-1146, 2015
- DOI for Quantitative Interaction Proteomics of Neurodegenerative Disease Proteins
- Download full text (pdf) of Quantitative Interaction Proteomics of Neurodegenerative Disease Proteins
-
Mutagenesis: smoking is associated with mosaic loss of chromosome Y
Part of Science, p. 81-83, 2015
-
Part of American Journal of Kidney Diseases, p. 602-612, 2015
-
Part of American Journal of Kidney Diseases, p. 591-601, 2015
-
Changes in secondary structure of α-synuclein during oligomerization induced by reactive aldehydes.
Part of Biochemical and Biophysical Research Communications - BBRC, p. 336-341, 2015
-
Part of PLOS Genetics, 2015
- DOI for The Influence of Age and Sex on Genetic Associations with Adult Body Size and Shape: A Large-Scale Genome-Wide Interaction Study
- Download full text (pdf) of The Influence of Age and Sex on Genetic Associations with Adult Body Size and Shape: A Large-Scale Genome-Wide Interaction Study
-
Part of PLOS Genetics, 2015
- DOI for Identification and Functional Characterization of G6PC2 Coding Variants Influencing Glycemic Traits Define an Effector Transcript at the G6PC2-ABCB11 Locus
- Download full text (pdf) of Identification and Functional Characterization of G6PC2 Coding Variants Influencing Glycemic Traits Define an Effector Transcript at the G6PC2-ABCB11 Locus
-
Part of Leukemia, p. 2069-2074, 2015
-
A comprehensive 1000 Genomes-based genome-wide association meta-analysis of coronary artery disease
Part of Nature Genetics, p. 1121-1130, 2015
-
Self-reported sleep disturbance is associated with Alzheimer's disease risk in men
Part of Alzheimer's & Dementia, p. 1090-1097, 2015
- DOI for Self-reported sleep disturbance is associated with Alzheimer's disease risk in men
- Download full text (pdf) of Self-reported sleep disturbance is associated with Alzheimer's disease risk in men
-
Convergent genetic and expression data implicate immunity in Alzheimer's disease
Part of Alzheimer's & Dementia, p. 658-671, 2015
-
Part of Alzheimer's & Dementia, p. 1180-1190, 2015
-
A novel multi-tissue RNA diagnostic of healthy ageing relates to cognitive health status
Part of Genome Biology, 2015
- DOI for A novel multi-tissue RNA diagnostic of healthy ageing relates to cognitive health status
- Download full text (pdf) of A novel multi-tissue RNA diagnostic of healthy ageing relates to cognitive health status
-
Part of Journal of Alzheimer's Disease, p. 63-72, 2015
- DOI for Increased Number of Plasma B Cells Producing Autoantibodies Against A beta(42) Protofibrils in Alzheimer's Disease
- Download full text (pdf) of Increased Number of Plasma B Cells Producing Autoantibodies Against A beta(42) Protofibrils in Alzheimer's Disease
-
Micellar extraction possesses a new advantage for the analysis of Alzheimer's disease brain proteome
Part of Analytical and Bioanalytical Chemistry, p. 1041-1057, 2015
-
Part of Journal of Alzheimer's Disease, p. 575-588, 2015
-
eta-Secretase processing of APP inhibits neuronal activity in the hippocampus
Part of Nature, p. 443-447, 2015
-
Part of Journal of Biological Chemistry, p. 14904-14914, 2015
-
Part of Amyloid, p. 76-87, 2014
-
Part of Nature Genetics, p. 624-628, 2014
-
Increased Inflammatory Response in Cytomegalovirus Seropositive Patients with Alzheimer's Disease
Part of PLOS ONE, 2014
- DOI for Increased Inflammatory Response in Cytomegalovirus Seropositive Patients with Alzheimer's Disease
- Download full text (pdf) of Increased Inflammatory Response in Cytomegalovirus Seropositive Patients with Alzheimer's Disease
-
Part of Sleep, p. 195-198, 2014
-
Part of Molecular Neurodegeneration, p. 13, 2014
- DOI for Abundance of A beta(5-x) x like immunoreactivity in transgenic 5XFAD, APP/PS1KI and 3xTG mice, sporadic and familial Alzheimer's disease
- Download full text (pdf) of Abundance of A beta(5-x) x like immunoreactivity in transgenic 5XFAD, APP/PS1KI and 3xTG mice, sporadic and familial Alzheimer's disease
-
Quantification of the Brain Proteome in Alzheimer's Disease Using Multiplexed Mass Spectrometry
Part of Journal of Proteome Research, p. 2056-2068, 2014
-
Gene-Wide Analysis Detects Two New Susceptibility Genes for Alzheimer's Disease
Part of PLOS ONE, 2014
- DOI for Gene-Wide Analysis Detects Two New Susceptibility Genes for Alzheimer's Disease
- Download full text (pdf) of Gene-Wide Analysis Detects Two New Susceptibility Genes for Alzheimer's Disease
-
Part of Journal of Internal Medicine, p. 202-203, 2014
-
Part of Neurobiology of Disease, p. 134-143, 2014
-
Part of Dementia and Geriatric Cognitive Disorders, p. 196-206, 2014
-
Part of Journal of Alzheimer's Disease, p. 871-881, 2014
-
Part of Neuroscience Letters, p. 7-12, 2014
-
Serial propagation of distinct strains of A beta prions from Alzheimer's disease patients
Part of Proceedings of the National Academy of Sciences of the United States of America, p. 10323-10328, 2014
-
Amyloid-beta-directed immunotherapy for Alzheimer's disease
Part of Journal of Internal Medicine, p. 284-295, 2014
- DOI for Amyloid-beta-directed immunotherapy for Alzheimer's disease
- Download full text (pdf) of Amyloid-beta-directed immunotherapy for Alzheimer's disease
-
Part of BMJ-BRIT MED J, 2014
-
Lack of exon 10 in the murine tau gene results in mild sensorimotor defects with aging
Part of BMC Neuroscience, p. 148, 2013
- DOI for Lack of exon 10 in the murine tau gene results in mild sensorimotor defects with aging
- Download full text (pdf) of Lack of exon 10 in the murine tau gene results in mild sensorimotor defects with aging
-
Re-evaluation of clinical dementia diagnoses with pittsburgh compound B positron emission tomography
Part of Dementia and Geriatric Cognitive Disorders Extra, p. 472-481, 2013
-
Microglial Markers are Elevated in the Prodromal Phase of Alzheimer's Disease and Vascular Dementia
Part of Journal of Alzheimer's Disease, p. 45-53, 2013
-
Part of Journal of Alzheimer's Disease, p. 29-40, 2013
-
Part of Acta neuropathologica communications, p. 60, 2013
-
Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer's disease
Part of Nature Genetics, p. 1452-U206, 2013
-
Part of PLOS ONE, 2013
- DOI for Decreased Proportion of Cytomegalovirus Specific CD8 T-Cells but No Signs of General Immunosenescence in Alzheimer's Disease
- Download full text (pdf) of Decreased Proportion of Cytomegalovirus Specific CD8 T-Cells but No Signs of General Immunosenescence in Alzheimer's Disease
-
Part of PLOS ONE, 2013
- DOI for Rare Variants in Calcium Homeostasis Modulator 1 (CALHM1) Found in Early Onset Alzheimer's Disease Patients Alter Calcium Homeostasis
- Download full text (pdf) of Rare Variants in Calcium Homeostasis Modulator 1 (CALHM1) Found in Early Onset Alzheimer's Disease Patients Alter Calcium Homeostasis
-
Part of Amyloid, p. 233-244, 2013
-
Part of Journal of Alzheimer's Disease, p. 673-679, 2013
-
Part of Molecular Psychiatry, p. 461-470, 2013
-
Part of Journal of Alzheimer's Disease, p. 611-621, 2013
- DOI for Prediction of Mild Cognitive Impairment that Evolves into Alzheimer's Disease Dementia within Two Years using a Gene Expression Signature in Blood: A Pilot Study
- Download full text (pdf) of Prediction of Mild Cognitive Impairment that Evolves into Alzheimer's Disease Dementia within Two Years using a Gene Expression Signature in Blood: A Pilot Study
-
Part of Journal of Neurochemistry, p. 131-144, 2013
-
Part of Acta neuropathologica communications, p. 56, 2013
-
Part of Journal of the American Medical Association (JAMA), p. 1941-1951, 2012
-
Part of Journal of Medical Genetics, 2012
-
Part of Acta Neuropathologica, p. 465-478, 2012
-
Part of Neurobiology of Aging, p. 10100-10100000000000000, 2012
-
Part of PLOS ONE, 2012
-
Part of European Journal of Clinical Nutrition, p. 885-890, 2012
-
Age-related somatic structural changes in the nuclear genome of human blood cells
Part of American Journal of Human Genetics, p. 217-228, 2012
-
Part of International Journal of Obesity, p. 119-129, 2012
-
Part of Journal of Neuroscience, p. 11750-11762, 2012
-
Part of Journal of Alzheimer's Disease, p. 273-276, 2012
-
Part of Nature Genetics, p. 659-669, 2012
-
Immunotherapy in Alzheimer's disease - targeting toxic A beta protofibrils
Part of European Neuropsychopharmacology, 2012
-
Part of Journal of Alzheimer's Disease, p. 939-947, 2012
-
Part of Neurobiology of Aging, p. 11590-115900000, 2011
-
Antibodies against alpha-synuclein reduce oligomerization in living cells
Part of PLOS ONE, 2011
- DOI for Antibodies against alpha-synuclein reduce oligomerization in living cells
- Download full text (pdf) of Antibodies against alpha-synuclein reduce oligomerization in living cells
-
Part of Neurodegenerative Diseases, p. 117-123, 2011
-
Novel Progranulin Mutation Detected in 2 Patients With FTLD
Part of Alzheimer Disease and Associated Disorders, p. 173-178, 2011
-
Part of Neurobiology of Aging, p. 1379-1387, 2011
-
In vivo imaging of astrocytosis in Alzheimer's disease: an ¹¹C-L-deuteriodeprenyl and PIB PET study
Part of European Journal of Nuclear Medicine and Molecular Imaging, p. 2202-2208, 2011
-
Loss of Astrocyte Polarization in the Tg-ArcSwe Mouse Model of Alzheimer's Disease
Part of Journal of Alzheimer's Disease, p. 711-722, 2011
-
Glucose metabolism and PIB binding in carriers of a His163Tyr presenilin 1 mutation
Part of Neurobiology of Aging, p. 1388-1399, 2011
-
Part of Free Radical Biology & Medicine, p. 428-437, 2011
-
Gelsolin co-occurs with Lewy bodies in vivo and accelerates alpha-synuclein aggregation in vitro
Part of Biochemical and Biophysical Research Communications - BBRC, p. 32-38, 2011
-
Vascular Risk Factors and Dementia: 40-Year Follow-Up of a Population-Based Cohort
Part of Dementia and Geriatric Cognitive Disorders, p. 460-466, 2011
-
Sensitive detection of A beta protofibrils by proximity ligation: relevance for Alzheimer's disease
Part of BMC Neuroscience, p. 124, 2010
-
Interference from Heterophilic Antibodies in Amyloid-beta Oligomer ELISAs
Part of Journal of Alzheimer's Disease, p. 1295-1301, 2010
-
Higher Cathepsin B Levels in Plasma in Alzheimer's Disease Compared to Healthy Controls
Part of Journal of Alzheimer's Disease, p. 1223-1230, 2010
-
Part of Journal of Alzheimer's Disease, p. 471-478, 2010
-
Stabilization of neurotoxic Alzheimer amyloid-beta oligomers by protein engineering
Part of Proceedings of the National Academy of Sciences of the United States of America, p. 15595-15600, 2010
-
Part of Journal of Biological Chemistry, p. 41517-41524, 2010
-
Part of Dementia and Geriatric Cognitive Disorders, p. 204-212, 2010
-
CALHM1 P86L polymorphism does not alter amyloid-beta or tau in cerebrospinal fluid
Part of Neuroscience Letters, p. 265-267, 2010
-
PBT2 Rapidly Improves Cognition in Alzheimer's Disease: Additional Phase II Analyses
Part of Journal of Alzheimer's Disease, p. 509-516, 2010
-
Heparan sulfate mediates amyloid-beta internalization and cytotoxicity
Part of Glycobiology, p. 533-541, 2010
-
Neurofilament ELISA validation
Part of JIM - Journal of Immunological Methods, p. 23-31, 2010
-
Pyroglutamate Abeta pathology in APP/PS1KI mice, sporadic and familial Alzheimer's disease cases
Part of Journal of neural transmission, p. 85-96, 2010
-
Part of Acta Neurologica Scandinavica, p. 186-193, 2010
-
Part of European Journal of Neuroscience, p. 852-863, 2010
-
Part of Acta Neurologica Scandinavica, p. 270-277, 2010
-
Part of International journal of Alzheimer's disease, p. 936580, 2010
-
Part of Journal of Alzheimer's Disease, p. 247-255, 2010
-
Impaired behavior of female tg-ArcSwe APP mice in the IntelliCage: A longitudinal study
Part of Behavioural Brain Research, p. 83-94, 2010
-
Separation and characterization of aggregated species of amyloid-beta peptides
Part of Analytical and Bioanalytical Chemistry, p. 2357-2366, 2010
-
Functional outcome is impaired following traumatic brain injury in aging Nogo-A/B-deficient mice
Part of Neuroscience, p. 540-551, 2009
-
Part of BMC Medical Genetics, p. 122, 2009
-
Part of BMC Medical Genetics, p. 131, 2009
-
Sällsynta mutationer leder till framtidens behandling
Part of Läkartidningen, p. 1396-1400, 2009
-
Part of Journal of Alzheimer's Disease, p. 79-87, 2009
-
Part of Journal of Alzheimer's Disease, p. 71-78, 2009
-
Part of Neurobiology of Disease, p. 425-434, 2009
-
Part of Diabetologia, p. 1504-1510, 2009
-
Genetic and pharmacological evidence of intraneuronal Abeta accumulation in APP transgenic mice
Part of FEBS Letters, p. 3021-3026, 2009
-
Part of Dementia and Geriatric Cognitive Disorders, p. 471-475, 2009
-
Frontotemporal dementia in a large Swedish family is caused by a progranulin null mutation
Part of Neurogenetics, p. 27-34, 2009
-
Part of Alzheimer Disease and Associated Disorders, p. 298-300, 2009
-
Part of Neurobiology of Aging, p. 1393-1405, 2009
-
Oligomerization partially explains the lowering of Aβ42 in Alzheimer's disease cerebrospinal fluid
Part of Neuro-degenerative diseases, p. 139-147, 2009
-
Part of The FEBS Journal, p. 995-1006, 2009
-
Genetic analysis of Alzheimer's disease in the Uppsala Longitudinal Study of Adult Men
Part of Dementia and Geriatric Cognitive Disorders, p. 59-68, 2009
-
Circulating immune complexes of A beta and IgM in plasma of patients with Alzheimer's disease
Part of Journal of neural transmission, p. 913-920, 2009
-
Part of Annals of Clinical Biochemistry, p. 235-240, 2009
-
Part of Biochemical and Biophysical Research Communications - BBRC, p. 872-876, 2009
-
Part of Dementia and Geriatric Cognitive Disorders, p. 458-464, 2009
-
USF1 gene variants contribute to metabolic traits in men in a longitudinal 32-year follow-up study
Part of Diabetologia, p. 464-472, 2008
-
Part of Brain Pathology, p. 548-561, 2008
-
Part of European Journal of Human Genetics, p. 171-5, 2008
-
Does APOE explain the linkage of Alzheimer’s disease to chromosome 19q13?
Part of American Journal of Medical Genetics Part B: Neuropsychiatric Genetics American Journal of Medical Genetics Part B: Neuropsychiatric Genetics, p. 778-83, 2008
-
The tau S305S mutation causes frontotemporal dementia with parkinsonism
Part of European Journal of Neurology, p. 156-161, 2008
-
Part of Lancet Neurology, p. 779-786, 2008
-
Part of Archives of Neurology, p. 256-63, 2008
-
Serum cystatin C and the risk of Alzheimer disease in elderly men
Part of Neurology, p. 1072-1079, 2008
-
No association between CALHM1 and Alzheimer's disease risk
Part of Cell, p. 993-994, 2008
-
Part of Archives of Neurology, p. 499-505, 2008
-
In vivo amyloid imaging with PET in frontotemporal dementia
Part of European Journal of Nuclear Medicine and Molecular Imaging, p. 100-106, 2008
-
Impaired insulin secretion increases the risk of Alzheimer disease
Part of Neurology, p. 1046-47, 2008
-
Sensitive ELISA detection of amyloid-β protofibrils in biological samples
Part of Journal of Neurochemistry, p. 334-345, 2007
-
Part of The FEBS Journal, p. 990-1000, 2007
-
Part of European Journal of Neuroscience, p. 882-889, 2007
-
Part of ACS Chemical Biology, p. 553-560, 2007
-
Attenuated amyloid-β aggregation and neurotoxicity owing to methionine oxidation
Part of NeuroReport, p. 559-563, 2007
-
Polymorphisms in the SCD1 gene: associations with body fat distribution and insulin sensitivity
Part of Obesity, p. 1732-1740, 2007
-
Part of Lipids, p. 451-456, 2007
-
Part of Journal of Neurochemistry, p. 854-862, 2007
-
Part of Neuroscience Letters, p. 127-131, 2007
-
Underskatta inte värdet av transgena djurmodeller av Alzheimers sjukdom
Part of Läkartidningen, p. 798-800, 2007
-
Increase in beta-Amyloid Levels in Cerebrospinal Fluid of Children with Down Syndrome
Part of Dementia and Geriatric Cognitive Disorders, p. 369-374, 2007
-
Reduction of Phosphorylated Tau during Memantine Treatment of Alzheimer's Disease
Part of Dementia and Geriatric Cognitive Disorders, p. 247-252, 2007
-
Longitudinal stability of CSF biomarkers in Alzheimer's disease
Part of Neuroscience Letters, p. 18-22, 2007
-
Association study of cholesterol-related genes in Alzheimer's disease
Part of Neurogenetics, p. 179-188, 2007
-
New Alzheimer's disease locus on chromosome 8
Part of Journal of Medical Genetics, p. 931-935, 2006
-
Phospholipid mass is increased in fibroblasts bearing the Swedish amyloid precursor mutation.
Part of Brain Res Bull, p. 79-85, 2006
-
Part of Neurobiol Aging, p. 67-77, 2006
-
Part of FEBS Journal, p. 2618-30, 2006
-
Part of Comb Chem High Throughput Screen, p. 801-6, 2005
-
Proteasome-mediated effects on amyloid precursor protein processing at the gamma-secretase site.
Part of Biochem J, p. 545-50, 2005
-
Part of World J Biol Psychiatry, p. 69-84, 2005
-
Konformationsförändrade proteiner orsakar neurodegenerativa sjukdomar
Part of Läkartidningen, p. 3542-3551, 2005
-
Amyloid-beta oligomers are inefficiently measured by enzyme-linked immunosorbent assay.
Part of Ann Neurol, p. 147-50, 2005
-
Familial presenile dementia with bitemporal atrophy.
Part of Dement Geriatr Cogn Disord, p. 287-92, 2004
-
Part of J Mol Biol, p. 145-59, 2004
-
The tau R406W mutation causes progressive presenile dementia with bitemporal atrophy.
Part of Dement Geriatr Cogn Disord, p. 298-301, 2004
-
Part of Neurosci Lett, p. 99-101, 2004
-
Clinical and molecular aspects of frontotemporal dementia.
Part of Neurodegener Dis, p. 218-24, 2004
-
Part of Science Translational Medicine
Articles, review/survey
-
Part of Upsala Journal of Medical Sciences, 2023
- DOI for A light at the end of the tunnel: from mutation identification to a potential treatment for Alzheimer’s disease
- Download full text (pdf) of A light at the end of the tunnel: from mutation identification to a potential treatment for Alzheimer’s disease
-
The Amyloid-beta Pathway in Alzheimer's Disease
Part of Molecular Psychiatry, p. 5481-5503, 2021
- DOI for The Amyloid-beta Pathway in Alzheimer's Disease
- Download full text (pdf) of The Amyloid-beta Pathway in Alzheimer's Disease
-
Part of Immunotherapy, p. 141-153, 2014
-
Part of ALZHEIMERS RES THER, p. 16, 2014
- DOI for Perspectives on future Alzheimer therapies: amyloid-beta protofibrils - a new target for immunotherapy with BAN2401 in Alzheimer's disease
- Download full text (pdf) of Perspectives on future Alzheimer therapies: amyloid-beta protofibrils - a new target for immunotherapy with BAN2401 in Alzheimer's disease
-
Part of Nutrition reviews, 2010
-
Animal models of amyloid-β-related pathologies in Alzheimer’s disease
Part of The FEBS Journal, p. 1389-1409, 2010
-
Part of Revista de Psiquiatria Clinica, p. 1-16, 2009
Conference papers
-
Journal of Labelled Compounds and Pharmaceuticals: Neurosciences session
Part of ISRS 2019, 2019
-
Seeding of cross linked alpha-synuclein oligomers in vitro and in vivo
2010
-
Seeding of cross linked alpha-synuclein oligomers in vitro and in vivo
2010
-
Details of neuropathology in Arctic Alzheimer's disease
Part of Abstracts of the XVIIth International Congress of Neuropathology (ICN 2010), Salzburg, Austria, 11-15 September 2010, p. 22-23, 2010
-
Morphological and functional differences of aldehyde-induced alpha-synuclein oligomers
Part of Amyloid - Journal of Protein Folding Disorders, p. 93-94, 2010
-
Effects of lipid peroxidation metabolites on alpha-synuclein aggregation
2009